James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Zillow Stock Is a Buy Despite Lousy Response to Earnings

Zillow stock may not look like much from a valuation standpoint, but give it time -- it's a story stock, and the story is moving forward for the better.

4 Big Pharma Stocks to Own After Q2 Earnings

Big Pharma has a lot to be proud of following some key second-quarter filings and revised full-year outlooks. Four stocks in particular look buy-worthy.

LL Stock: Lumber Liquidators Is Even Worse Than Imagined

LL stock may be in the gutter, but all things considered, that's where it deserves to be. Lumber Liquidators dug itself into a hole it may never fully get out of.

Amazon (AMZN) vs. Netflix (NFLX): Which Highflying Stock Will Face Reality First?

AMZN stock and NFLX stock have a lot of parallels ... on the surface. One of them, however, is up on a wobbly pedestal.

Why Allstate Corp. (ALL), Shire PLC (SHPG) and Norwegian Cruise Line Holdings Ltd (NCLH) Are 3 of Today’s Worst Stocks

Allstate (ALL), Shire (SHPG) and Norwegian Cruise Line Holdings (NCLH) couldn't win for losing on Tuesday. Here's what happened.